Pasar al contenido principal

CARACTERIZACION DE SUBPOBLACIONES DE VESICULAS EXTRACELULARES CEREBRALES: HACIA LA IDENTIFICACION DE NUEVOS BIOMARCADORES Y DIANAS TERAPEUTICAS EN LA ENFERMEDAD DE ALZHEIMER

PID2022-137426OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNITAT VALENCIANA PARA LA GESTIÓN DEL INSTITUTO DE INVESTIGACIÓN SANITARIA Y BIOM

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers

  • Salvat-Rovira, Nil|||0009-0005-8515-3819
  • Vázquez-Oliver, Anna|||0000-0002-9842-7656
  • Rivas Asensio, Elisa|||0009-0006-1645-0059
  • Herrero-Lorenzo, Marina|||0000-0003-2693-0700
  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Izquierdo, Cristina
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Martí, Eulàlia|||0000-0002-1030-3158
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pérez-González, Rocío|||0000-0002-0641-2001
Extracellular vesicles (EVs) in cerebrospinal fluid (CSF) represent a valuable source of biomarkers for central nervous system (CNS) diseases, offering new pathways for diagnosis and monitoring. However, existing methods for isolating EVs from CSF often prove to be labor-intensive and reliant on specialized equipment, hindering their clinical application. In this study, we present a novel, clinically compatible method for isolating EVs from CSF. We optimized the use of ExoGAG, a commercially available reagent that has been tested in plasma, urine and semen, and compared it directly with differential ultracentrifugation using Western blotting, protein quantification, nanoparticle tracking analysis, and cryogenic electron microscopy. Additionally, we analyzed the presence of specific microRNAs (miRNAs) known to be present in CSF-derived EVs. Our data demonstrate that ExoGAG is an effective method for isolating EVs from CSF, yielding a higher amount of EVs compared to traditional ultracentrifugation methods, and with comparable levels of specific miRNAs. In conclusion, the use of ExoGAG in a clinical setting may facilitate the testing of biomarkers essential for tracking brain pathology in CNS diseases.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers

  • Salvat-Rovira, Nil
  • Vázquez-Oliver, Anna
  • Rivas-Asensio, Elisa
  • Herrero-Lorenzo, Marina
  • Gámez-Valero, Ana
  • Perez-Perez, Jesús
  • Izquierdo, Cristina
  • Campolongo, Antonia
  • Martí, Eulàlia
  • Kulisevsky, Jaime
  • Pérez-González, Rocío
This article belongs to the Special Issue Role of Extracellular Vesicles in Immunology, Extracellular vesicles (EVs) in cerebrospinal fluid (CSF) represent a valuable source of biomarkers for central nervous system (CNS) diseases, offering new pathways for diagnosis and monitoring. However, existing methods for isolating EVs from CSF often prove to be labor-intensive and reliant on specialized equipment, hindering their clinical application. In this study, we present a novel, clinically compatible method for isolating EVs from CSF. We optimized the use of ExoGAG, a commercially available reagent that has been tested in plasma, urine and semen, and compared it directly with differential ultracentrifugation using Western blotting, protein quantification, nanoparticle tracking analysis, and cryogenic electron microscopy. Additionally, we analyzed the presence of specific microRNAs (miRNAs) known to be present in CSF-derived EVs. Our data demonstrate that ExoGAG is an effective method for isolating EVs from CSF, yielding a higher amount of EVs compared to traditional ultracentrifugation methods, and with comparable levels of specific miRNAs. In conclusion, the use of ExoGAG in a clinical setting may facilitate the testing of biomarkers essential for tracking brain pathology in CNS diseases., This study was supported by CIBERNED (Centro de Investigación Biomédica en Red-Enfermedades Neurodegenerativas, CB06/05/0047 group), the PID2022-137426OA-I00 to R.P.-G-from the Ministerio de Ciencia e Innovación, Spain, and by the PI17/001885 to J.P.-P. from the Fondo de Investigaciones Sanitarias–Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER). N.S.-R. was supported by the Programa Investigo (Ministerio de Trabajo y Economía Social, MITES, Spain), funded by the EU (NextGenerationEU). A.V.-O. is employed by CIBERNED (ISCIII). R.P.-G. is a recipient of a Miguel Servet fellowship from the ISCIII (CP21/00009)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell Type-Specific Extracellular Vesicles in Mouse Brain: Proteomic Signatures Highlight Astrocytic GlialCAM Network and GPCR Enrichment

  • Lucart-Sanchez, Alba M.
  • Sellés-Climent, Edward
  • Navarro-Calvo, Jorge
  • Pont-Espinós, Guillem
  • Gómez-Sánchez, José A.
  • Estévez, Raúl
  • Valor, Luis Miguel
  • Pérez-González, Rocío
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al. 2025) partner repository with the dataset identifier PXD071055., Extracellular vesicles (EVs) mediate intercellular communication in the central nervous system (CNS) and are emerging as biomarkers of brain health and disease. However, the molecular composition of cell type-specific brain EVs, particularly astrocyte-derived EVs (ADEVs), remains poorly defined. We performed comparative proteomic analysis of neuronal (NDEVs), microglial (MDEVs), and ADEVs from mouse brain using magnetic immunocapture and LC-MS/MS proteomic profiling. Each EV subtype displayed distinct molecular fingerprints. NDEVs were enriched in synaptic and neurogenesis-related proteins (e.g., APP, SNAP25, GPR158, and BDNF), whereas MDEVs contained immune and phagocytic markers (e.g., TMEM119, CX3CR1, CD11b). Strikingly, the ADEV proteome closely mirrored the recently characterized GlialCAM interactome from leukodystrophy research, encompassing GlialCAM/MLC1 and associated partners involved in ion and water homeostasis (EAAT1/2, AQP4, GJA1), together with GPCRs such as GPRC5B. This overlap suggests that ADEVs encapsulate a molecular scaffold characteristic of astrocytic endfeet, potentially extending their signaling functions to the extracellular space. In conclusion, our study provides a detailed comparative proteomic characterization of brain cell type-specific EVs, revealing that ADEVs contain the GlialCAM/MLC1 network and GPCRs. These findings identify candidate molecular signatures that support the future investigation of ADEVs for biomarker development and provide a proteomic framework for exploring their relationship with astrocytic endfoot biology, blood-brain barrier (BBB)-associated pathways, and neurodegenerative disorders., PID2022-137426OA-I00 funded by MICIU/AEI/10.13039/501100011033/ and by FSE+, and the EU Joint Programme- Neurodegenerative Diseases (JPND2022-115, CP22/00050) - EPI-3E. R.P.G. is recipient of a Miguel Servet fellowship CP21/00009 from the Instituto de Salud Carlos III (ISCIII). Work in the Estévez lab was supported by PID2024-159674NB-100 funded by MICIU/AEI/10.13039/501100011033/ and by FEDER/UE. Dr. Valor's research is supported by CNS2022-136169 funded by Ministerio de Ciencia e Innovación—NextGenerationEU 2021–2023, and PI23/01568 funded by ISCIII and Fondo Europeo de Desarrollo Regional 2014–2020. J.N.C. is recipient of a predoctoral fellowship from ISABIAL (2024/D/4)., Peer reviewed, Modelo experimental animal, Mamíferos - Roedores